Sales rise 6.67% to Rs 45.23 crore
Net profit of Jagsonpal Pharmaceuticals rose 173.97% to Rs 2.00 crore in the quarter ended June 2019 as against Rs 0.73 crore during the previous quarter ended June 2018. Sales rose 6.67% to Rs 45.23 crore in the quarter ended June 2019 as against Rs 42.40 crore during the previous quarter ended June 2018. ParticularsQuarter EndedJun. 2019Jun. 2018% Var.Sales45.2342.40 7 OPM %4.952.92 -PBDT2.791.16 141 PBT2.500.91 175 NP2.000.73 174Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
